Results of KEYNOTE-023 and pembrolizumab plus pomalidomide trials for multiple myeloma
Jesús San Miguel
Phase I trial results for nivolumab and pembrolizumab in lymphoma and multiple myeloma
ENDEAVOUR, ASPIRE and TOURMALINE-MM1 trial results for multiple myeloma
The impact of new drugs and the changing role of transplants in multiple myeloma
Treatment at first relapse in multiple myeloma: how to choose a drug?